Diet
UltraSound
Diabetes

Cancer & Biopsy
Germanium
Heart Disease
Free Radicals
IV Chelation Therapy

Vibrant Life Home Web
Family Of Three Chelation Formulas
MSM
Other VL Products
The Wednesday Letter
Frequently Asked Questions
Testimonials
Karl Loren Web


Shopping Cart

Separate Search Page
or search below

Loading
Navigation Help

Oral Chelation Therapy
Other

Ingredients
Technical
Write To Karl Loren Table Of Contents

Search Results:  Biopsy And Seeding, Review Articles

Cancer & Biopsy

Continuing Medical Education

Results for your query on July 18, 2000
Search all fields for: seeding And biopsy
Published in 1966 through 1999
Only select references with abstracts available
Show references published in English only
With an article type of: REVIEW
Documents: 1 to 47 of 47
Top Of Menu

1 Haddad FS, et al; Seeding and perineal implantation of prostatic cancer in the track of the biopsy needle: three case reports and a review of the literature. (J Surg Oncol, 1987 Jul, Abstract available) [MEDLINE]
2 John TG, et al; Needle track seeding of primary and secondary liver carcinoma after percutaneous liver biopsy. (HPB Surg, 1993, Abstract available) [MEDLINE]
3 Preece PE, et al; Cytodiagnosis and other methods of biopsy in the modern management of breast cancer. (Semin Surg Oncol, 1989, Abstract available) [MEDLINE]
4 Smith EH; Complications of percutaneous abdominal fine-needle biopsy. Review. (Radiology, 1991 Jan, Abstract available) [MEDLINE]
5 Herts BR, et al; The current role of percutaneous biopsy in the evaluation of renal masses. (Semin Urol Oncol, 1995 Nov, Abstract available) [MEDLINE]
6 Roussel F, et al; Evaluation of large-needle biopsy for the diagnosis of cancer. (Acta Cytol, 1995 May, Abstract available) [MEDLINE]
7 John TG, et al; Needle track seeding of primary and secondary liver carcinoma after percutaneous liver biopsy. (HPB Surg, 1993, Abstract available) [MEDLINE]
8 Smith EH; The hazards of fine-needle aspiration biopsy. (Ultrasound Med Biol, 1984 Sep, Abstract available) [MEDLINE]
9 Harolds JA; Stereotactically guided needle biopsy of the breast for nonpalpable lesions. (J Okla State Med Assoc, 1993 Dec, Abstract available) [MEDLINE]
10 Pitman MB; Fine needle aspiration biopsy of the liver. Principal diagnostic challenges. (Clin Lab Med, 1998 Sep, Abstract available) [MEDLINE]

Menu Position #10

11 Midena E, et al; Fine needle aspiration biopsy in ophthalmology. (Surv Ophthalmol, 1985 May, Abstract available) [MEDLINE]
12 Shives TC; Biopsy of soft-tissue tumors. (Clin Orthop, 1993 Apr, Abstract available) [MEDLINE]
13 Grimm PD, et al; Does brachytherapy have a role in the treatment of prostate cancer? (Hematol Oncol Clin North Am, 1996 Jun, Abstract available) [MEDLINE]
14 Scardino PT, et al; Local control of prostate cancer with radiotherapy: frequency and prognostic significance of positive results of postirradiation prostate biopsy. (NCI Monogr, 1988, Abstract available) [MEDLINE]
15 Andersson L, et al; Fine needle aspiration biopsy for diagnosis and follow-up of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. (Scand J Urol Nephrol Suppl, 1994, Abstract available) [MEDLINE]
16 Harolds JA; Stereotactically guided needle biopsy of the breast for nonpalpable lesions. (J Okla State Med Assoc, 1993 Dec, Abstract available) [MEDLINE]
17 Ryan PG, et al; Perineal prostatic tumour seedling after 'Tru-Cut' needle biopsy: case report and review of the literature. (Eur Urol, 1990, Abstract available) [MEDLINE]
18 Ayar D, et al; Needle-track metastasis after transthoracic needle biopsy. (J Thorac Imaging, 1998 Jan, Abstract available) [MEDLINE]
19 Alagaratnam TT, et al; Wound implantation--A surgical hazard. (Br J Surg, 1977 Dec, Abstract available) [MEDLINE]
20 Carr RJ, et al; A review of tumours of the deep lobe of the parotid salivary gland. (Br J Oral Maxillofac Surg, 1986 Jun, Abstract available) [MEDLINE]

Menu Position #20

21 Gunnarsson G, et al; Liver abscesses due to Staphylococcus aureus in a patient with AIDS who underwent small bowel biopsy: case report and review. (Clin Infect Dis, 1994 May, Abstract available) [MEDLINE]
22 Cuschieri A; Laparoscopic management of cancer patients. (J R Coll Surg Edinb, 1995 Feb, Abstract available) [MEDLINE]
23 Cava A, et al; Subcutaneous metastasis following laparoscopy in gastric adenocarcinoma. (Eur J Surg Oncol, 1990 Feb, Abstract available) [MEDLINE]
24 Kaye KW, et al; Detailed preliminary analysis of 125iodine implantation for localized prostate cancer using percutaneous approach. (J Urol, 1995 Mar, Abstract available) [MEDLINE]
25 Shields JA, et al; Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture. (Arch Ophthalmol, 1997 Jun, Abstract available) [MEDLINE]
26 Connolly B, et al; Scrofuloderma of the lower extremity treated with wide resection: a case report and review of the literature. (Am J Orthop, 1999 Jul, Abstract available) [MEDLINE]
27 Nag S, et al; American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. (Int J Radiat Oncol Biol Phys, 1999 Jul, Abstract available) [MEDLINE]
28 Soloway MS, et al; Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma. (Prog Clin Biol Res, 1989, Abstract available) [MEDLINE]
29 Hertzer NR, et al; An interpretive review of lymphoma of the stomach. (Surg Gynecol Obstet, 1976 Jul, Abstract available) [MEDLINE]
30 Pasquier B, et al; Extraneural metastases of astrocytomas and glioblastomas: clinicopathological study of two cases and review of literature. (Cancer, 1980 Jan, Abstract available) [MEDLINE]

Menu Position #30

31 Johnstone PA, et al; Port site recurrences after laparoscopic and thoracoscopic procedures in malignancy. (J Clin Oncol, 1996 Jun, Abstract available) [MEDLINE]
32 Palmer JD, et al; Extracranial osseous metastases from intracranial meningioma. (Br J Neurosurg, 1994, Abstract available) [MEDLINE]
33 Frick OL; Food allergy in atopic dogs. (Adv Exp Med Biol, 1996, Abstract available) [MEDLINE]
34 Henderson RA, et al; Surgical management of cancer. (Mod Vet Pract, 1984 Aug, Abstract available) [MEDLINE]
35 Ulbright TM; Testis risk and prognostic factors. The pathologist's perspective. (Urol Clin North Am, 1999 Aug, Abstract available) [MEDLINE]
36 Patil AA, et al; Nonresective treatment of pineoblastoma: a case report. (Surg Neurol, 1995 Oct, Abstract available) [MEDLINE]
37 Vicini FA, et al; A comprehensive review of prostate cancer brachytherapy: defining an optimal technique. (Int J Radiat Oncol Biol Phys, 1999 Jun, Abstract available) [MEDLINE]
38 Pallini R, et al; Bone metastasis associated with shunt-related peritoneal deposits from a pineal germinoma. Case report and review of the literature. (Acta Neurochir (Wien), 1991, Abstract available) [MEDLINE]
39 Martino R, et al; Leukemic dermal infiltrate at the exit site of a central venous catheter. (Haematologica, 1993 Mar, Abstract available) [MEDLINE]
40 Gerber GS, et al; Endourological management of upper tract urothelial tumors. (J Urol, 1993 Jul, Abstract available) [MEDLINE]

Menu Position #40

41 Schnorr JA Jr, et al; Hyperreactio luteinalis associated with pregnancy: a case report and review of the literature. (Am J Perinatol, 1996 Feb, Abstract available) [MEDLINE]
42 Jellinger KA, et al; Primary central nervous system lymphomas--an update [editorial] (J Cancer Res Clin Oncol, 1992, Abstract available) [MEDLINE]
43 Astoul P; Pleural mesothelioma. (Curr Opin Pulm Med, 1999 Jul, Abstract available) [MEDLINE]
44 Lyons MK, et al; Posterior fossa ependymomas: report of 30 cases and review of the literature. (Neurosurgery, 1991 May, Abstract available) [MEDLINE]
45 McLaughlin MP, et al; Ependymoma: results, prognostic factors and treatment recommendations. (Int J Radiat Oncol Biol Phys, 1998 Mar, Abstract available) [MEDLINE]
46 Nori D, et al; Current issues in techniques of prostate brachytherapy. (Semin Surg Oncol, 1997 Nov, Abstract available) [MEDLINE]
47 Gerber GS, et al; Endourological management of upper tract urothelial tumors. (J Urol, 1993 Jul, Abstract available) [MEDLINE]

Clinical | Non-clinical | Boston University | Physician's World | HealthStream | Reuters Medical | Newswire | Doody's Book Review | Software Reviews | Blackwell Science | Munksgaard | Your Health | Your Lifestyle | Your Research | MedGate Member Login


We subscribe to the HONcode principles
of the Health On the Net Foundation

Send comments to support@healthgate.com
Copyright © 2000 HealthGate® Data Corp.

-------------- -------------- -------------- -------------- --------------

Continuing Medical Education


NLM database Documents


 

Record 1 from database: MEDLINE
Return To Top

Title
Seeding and perineal implantation of prostatic cancer in the track of the biopsy needle: three case reports and a review of the literature.
Author
Haddad FS; Somsin AA
Address
 
Source
J Surg Oncol, 1987 Jul, 35:3, 184-91
Abstract
Several months (an average of 12.86 months) after perineal needling of the cancerous prostate for the purpose of obtaining tissue for biopsy, a tumor nodule becomes clinically evident in the subcutaneous tissue of the perineum, at the site of the needling in 0.34% of the cases. This nodule presents the same histological picture as the biopsy of the prostatic tumor. This is a review of 15 such cases (12 collected from the literature and an additional three unpublished cases, two of which are personal observations). At the time of needling, no metastases could be clinically detected in any of the patients; the serum acid phosphatase was normal in 73% of them. The average age of the patients was 65.66 years. The perineal nodule was tender in 40% of the cases; its average size was 2.5 cm. Excision of the nodule was the most frequently employed form of management. At the time of reporting, 60% of the patients were living and well, for an average of 18.56 months after excision. In order to prevent perineal implantation, especially in patients who are at risk, it is suggested that a fine needle be employed to obtain prostatic tissue for biopsy, and that every possible therapeutic effort be made.
Language of Publication
English
Unique Identifier
87256042

Return To Top


MeSH Heading (Major)
Neoplasm Seeding|*; Perineum|*/PA; Prostatic Neoplasms|*PA
MeSH Heading
Adenocarcinoma|PA; Aged; Biopsy, Needle|AE/MT; Case Report; Human; Male; Middle Age; Prognosis; Prostate|PA; Time Factors

Publication Type
JOURNAL ARTICLE; REVIEW
ISSN
0022-4790
Country of Publication
UNITED STATES

Record 2 from database: MEDLINE
Return To Top

Title
Needle track seeding of primary and secondary liver carcinoma after percutaneous liver biopsy.
Author
John TG; Garden OJ
Address
University Department of Surgery, Royal Infirmary, Edinburgh, UK.
Source
HPB Surg, 1993, 6:3, 199-203; discussion 203-4
Abstract
Seeding of tumour in the needle track following percutaneous needle biopsy of liver neoplasms is rarely reported. We describe two such cases following the needle biopsy of an hepatocellular carcinoma and secondary colorectal carcinoma respectively. The risk of needle track recurrence of liver tumours should not be regarded as insignificant. The diagnosis of liver neoplasms may be achieved by non-invasive modalities, and their needle biopsy should be reserved for cases not amenable to surgical resection.
Language of Publication
English
Unique Identifier
93257372

Return To Top


MeSH Heading (Major)
Adenocarcinoma|*PA/*SC; Biopsy, Needle|*AE/IS; Carcinoma, Hepatocellular|*PA/*SC; Liver Neoplasms|*PA/*SC; Neoplasm Seeding|*
MeSH Heading
Aged; Case Report; Colonic Neoplasms|PA; Female; Human; Ligaments|PA; Male; Middle Age; Muscular Diseases|PA

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
0894-8569
Country of Publication
SWITZERLAND

Record 3 from database: MEDLINE
Return To Top

Title
Cytodiagnosis and other methods of biopsy in the modern management of breast cancer.
Author
Preece PE; Hunter SM; Duguid HL; Wood RA
Address
Department of Surgery, University of Dundee, Scotland, United Kingdom.
Source
Semin Surg Oncol, 1989, 5:2, 69-81
Abstract
Since 1970 fine-needle aspiration cytology for breast tumours has grown in popularity and is now routinely used in the initial diagnosis of palpable breast masses in the United States and other parts of the world. Fast staining methods of the aspirate enables reporting within 10 minutes of the aspirate being performed. Training and experience is important in obtaining satisfactory smears for diagnosis, and pitfalls are false-negative and false-positive findings, which may have dire consequences for the patient if cytological diagnosis is the final arbiter. Conditions such as benign mammary dysplasia and sclerosing adenosis are the most common sources of highly cellular smears and often show marked atypia, which makes distinction from carcinoma difficult. Also, atypical papillary formations present a diagnostic problem, and biopsy is indicated to exclude a papillary carcinoma. Fine-needle aspirations very seldom cause traumatic complications, and these are usually of a minor degree. Seeding along the needle track has occurred, but in most cases with a larger-caliber (18 s.e.g.) needle. Aspiration itself has been shown to have no effect on the survival rates in breast carcinoma. Contemporary reports show that around 90% of cases of breast cancer can be detected with confidence by means of this procedure. The reduction in scar formation facilitates future evaluation of the patient as scar tissue often interferes with the interpretation of mammograms. Cost effectiveness is evident in terms of decreased use of anaesthetics and operating time and a reduction in the use of frozen section histology by about 80%.(ABSTRACT TRUNCATED AT 250 WORDS)
Language of Publication
English
Unique Identifier
89266375

Return To Top


MeSH Heading (Major)
Biopsy, Needle|IS/*MT; Breast Neoplasms|*DI/PA; Cytodiagnosis|EC/IS/*MT
MeSH Heading
Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Female; Human; Sensitivity and Specificity

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
8756-0437
Country of Publication
UNITED STATES

Record 4 from database: MEDLINE
Return To Top

Title
Complications of percutaneous abdominal fine-needle biopsy. Review.
Author
Smith EH
Address
Department of Radiology, University of Massachusetts Medical Center, Worcester 01655.
Source
Radiology, 1991 Jan, 178:1, 253-8
Abstract
To determine whether the increasing use of percutaneous fine-needle biopsy of abdominal lesions is associated with an increase in serious complications, the author updated a literature search and evaluated a questionnaire (distributed among selected hospitals in the United States in 1986 and 1987) that followed up a questionnaire distributed in 1983. The updated literature review revealed a total of 24 deaths and 20 needle tract seedings. The updated questionnaire revealed five deaths after 16,381 biopsies (0.031%), whereas the previous questionnaire had shown four deaths after 63,108 biopsies (0.006%). Two similar European questionnaires revealed mortality rates of 0.008% and 0.018%, respectively. Of the total of 33 deaths, 21 involved biopsies of liver lesions; six involved pancreatic biopsies. Seventeen of the 21 deaths after liver biopsies were secondary to hemorrhage; five of the six deaths after pancreatic biopsies were due to pancreatitis. Of the 23 instances of needle tract seeding, 10 occurred after biopsies of pancreatic malignancies. The frequencies of needle tract seeding in the four questionnaires were 0.005%, 0.006%, 0.003%, and 0.009%, respectively. Although infrequent, serious complications may be associated with this procedure. The author makes suggestions that may help minimize them.
Language of Publication
English
Unique Identifier
91074991

Return To Top


MeSH Heading (Major)
Abdominal Neoplasms|*PA; Biopsy, Needle|*AE; Neoplasm Seeding|*
MeSH Heading
Europe|EP; Human; Liver Neoplasms|PA; Mortality; Pancreatic Neoplasms|PA; Questionnaires; United States|EP

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, MULTICASE
ISSN
0033-8419
Country of Publication
UNITED STATES

 

Record 5 from database: MEDLINE
Return To Top

Title
The current role of percutaneous biopsy in the evaluation of renal masses.
Author
Herts BR; Baker ME
Address
Division of Radiology, Cleveland Clinic Foundation, OH 44195, USA.
Source
Semin Urol Oncol, 1995 Nov, 13:4, 254-61
Abstract
Percutaneous biopsy of intraabdominal masses is a safe and accurate means of obtaining a tissue diagnosis without surgical exploration. It is often sufficient to determine treatment plans and in many instances, obviates the need for surgery. Percutaneous biopsy of renal masses has traditionally had a limited role in the United States. However, with a recent increase in the detection of small renal masses because of the widespread use of abdominal computed tomography (CT), there is an increasing role for percutaneous biopsy in the management of renal masses. Percutaneous biopsy of renal masses is indicated to differentiate between a primary renal cell carcinoma and metastatic disease in patients with a known extrarenal primary. Percutaneous biopsy is also indicated to establish a diagnosis of renal lymphoma and abscess. Complications of percutaneous biopsy include bleeding, pneumothorax, and tumor seeding along the needle tract; fortunately, these complications are uncommon. We will review the indications, techniques, complications, sensitivity, and accuracy of CT and ultrasound-guided biopsy of renal masses. Urologists and radiologists should both be familiar with the indications and contraindications of percutaneous biopsy to insure the appropriate management of renal masses.
Language of Publication
English
Unique Identifier
96167144

Return To Top


MeSH Heading (Major)
Biopsy, Needle|AE/CT/*MT; Kidney Neoplasms|*DI/SC/US
MeSH Heading
Blood Coagulation Disorders|DI; Human; Neoplasm Seeding; Sensitivity and Specificity

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
1081-0943
Country of Publication
UNITED STATES

Record 6 from database: MEDLINE
Return To Top

Title
Evaluation of large-needle biopsy for the diagnosis of cancer.
Author
Roussel F; Nouvet G
Address
Laboratoire d'Histologie, Centre Hospitalier et Universitaire de Rouen, HÈopital Charles Nicolle, France.
Source
Acta Cytol, 1995 May, 39:3, 449-52
Abstract
The arguments for a choice between a large or fine needle in the diagnosis of tumors are still unclear. This paper reviews the advantages and disadvantages of large-needle biopsy and fine needle aspiration. Reports indicate that although the procedures have the same diagnostic efficacy, the risk of tumor seeding is far higher following large-needle biopsy. For this reason it should be avoided for the diagnosis of cancer. The risk of tumor seeding after fine needle aspiration may be reduced by performance through a cover of normal parenchyma, by maintaining suction during withdrawal of the needle and by examining samples for quality during the procedure.
Language of Publication
English
Unique Identifier
95282546

Return To Top


MeSH Heading (Major)
Biopsy, Needle|AE/*MT; Neoplasms|*DI
MeSH Heading
Abdominal Neoplasms|DI; Carcinoma, Bronchogenic|DI; Evaluation Studies; Human; Lung Neoplasms|DI; Male; Mesothelioma|DI; Neoplasm Seeding; Pleural Neoplasms|DI; Prostatic Neoplasms|DI; Risk Factors

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0001-5547
Country of Publication
UNITED STATES

Record 7 from database: MEDLINE
Return To Top

Title
Needle track seeding of primary and secondary liver carcinoma after percutaneous liver biopsy.
Author
John TG; Garden OJ
Address
University Department of Surgery, Royal Infirmary, Edinburgh, UK.
Source
HPB Surg, 1993, 6:3, 199-203; discussion 203-4
Abstract
Seeding of tumour in the needle track following percutaneous needle biopsy of liver neoplasms is rarely reported. We describe two such cases following the needle biopsy of an hepatocellular carcinoma and secondary colorectal carcinoma respectively. The risk of needle track recurrence of liver tumours should not be regarded as insignificant. The diagnosis of liver neoplasms may be achieved by non-invasive modalities, and their needle biopsy should be reserved for cases not amenable to surgical resection.
Language of Publication
English
Unique Identifier
93257372

Return To Top


MeSH Heading (Major)
Adenocarcinoma|*PA/*SC; Biopsy, Needle|*AE/IS; Carcinoma, Hepatocellular|*PA/*SC; Liver Neoplasms|*PA/*SC; Neoplasm Seeding|*
MeSH Heading
Aged; Case Report; Colonic Neoplasms|PA; Female; Human; Ligaments|PA; Male; Middle Age; Muscular Diseases|PA

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
0894-8569
Country of Publication
SWITZERLAND

Record 8 from database: MEDLINE
Return To Top

Title
The hazards of fine-needle aspiration biopsy.
Author
Smith EH
Address
 
Source
Ultrasound Med Biol, 1984 Sep, 10:5, 629-34
Abstract
Review of the literature and the results of the hospital survey substantiate the widely held belief that fine-needle aspiration biopsy is a very safe procedure. However, serious and even fatal complications, although rare, can and do occur and it is important to be aware of the possibility and to take all the appropriate precautions in order to reduce their incidence.
Language of Publication
English
Unique Identifier
85169451

Return To Top


MeSH Heading (Major)
Biopsy, Needle|*AE
MeSH Heading
Animal; Cats; Female; Hemorrhage|ET; Human; Infection|ET; Male; Mice; Mortality; Neoplasm Seeding; Rabbits

Publication Type
JOURNAL ARTICLE; REVIEW
ISSN
0301-5629
Country of Publication
ENGLAND

Record 9 from database: MEDLINE
Return To Top

Title
Stereotactically guided needle biopsy of the breast for nonpalpable lesions.
Author
Harolds JA
Address
Baptist Medical Center of Oklahoma, Oklahoma City 73112.
Source
J Okla State Med Assoc, 1993 Dec, 86:12, 604-12
Abstract
Stereotactically guided needle biopsy of the breast is a new diagnostic technique in this country to obtain samples of a nonpalpable area deemed suspicious for malignancy on mammography. This article is a review of the literature, a report of a case, and a description of the technique. This procedure, when performed with a large core biopsy needle, appears to be about as accurate as surgical biopsy.
Language of Publication
English
Unique Identifier
94172481

Return To Top


MeSH Heading (Major)
Biopsy, Needle|IS/*MT; Breast Neoplasms|*PA; Stereotaxic Techniques|*
MeSH Heading
Case Report; Clinical Protocols; Female; Human; Neoplasm Seeding

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
0030-1876
Country of Publication
UNITED STATES

Record 10 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Fine needle aspiration biopsy of the liver. Principal diagnostic challenges.
Author
Pitman MB
Address
Harvard Medical School, Boston, Massachusetts, USA.
Source
Clin Lab Med, 1998 Sep, 18:3, 483-506, vi
Abstract
Fine needle aspiration biopsy (FNAB) is the diagnostic procedure of choice for evaluation of liver lesions. Although primarily applied to malignant disease, it is also used in the evaluation of benign conditions. Improvements in imaging techniques and advances in cytologic interpretations, as well as production of new biopsy needles, have all contributed to the rapid increase in radiologically guided liver FNAB.
Language of Publication
English
Unique Identifier
98414788

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Biopsy, Needle|AE/CT/*MT; Carcinoma, Hepatocellular|*DI/SC; Cholangiocarcinoma|*DI; Liver Neoplasms|*DI/SC; Neoplasm Metastasis|*DI
MeSH Heading
Bile Ducts|CY; Diagnosis, Differential; Human; Liver|CY; Neoplasm Seeding

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0272-2712
Country of Publication
UNITED STATES

Record 11 from database: MEDLINE
Return To Top
Return To Menu Position #10

 

Title
Fine needle aspiration biopsy in ophthalmology.
Author
Midena E; Segato T; Piermarocchi S; Boccato P
Address
 
Source
Surv Ophthalmol, 1985 May, 29:6, 410-22
Abstract
When noninvasive techniques fail to confirm or rule out the suspicion of a malignant lesion, fine needle aspiration biopsy may provide an efficient, economical and relatively safe method of obtaining material for cytological study. The technique may also be valuable for intraoperative morphological evaluation. Traumatic complications produced by fine (21-25 gauge) needles are infrequent and almost never serious, and concerns about tumor seeding through the procedure have been largely dispelled by recent studies. Reliable results require a high level of skill in performing the aspiration procedure and in cytologically examining the small amount of material obtained. The authors review the history, applications, techniques and complications of fine needle aspiration biopsy, presenting guidelines for and illustrations of its use in specific ophthalmic situations.
Language of Publication
English
Unique Identifier
85245202

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Biopsy, Needle|*/AE; Eye Diseases|DI/*PA
MeSH Heading
Animal; Choroid Neoplasms|DI/PA; Eye Neoplasms|DI/PA; Human; Melanoma|DI/PA; Methods; Optic Nerve Diseases|DI; Orbital Neoplasms|DI; Rabbits

Publication Type
JOURNAL ARTICLE; REVIEW
ISSN
0039-6257
Country of Publication
UNITED STATES

Record 12 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Biopsy of soft-tissue tumors.
Author
Shives TC
Address
Department of Orthopedics, Mayo Clinic, Rochester, Minnesota 55905.
Source
Clin Orthop, 1993 Apr, :289, 32-5
Abstract
Biopsy is an integral part of the overall management of patients with soft-tissue sarcoma. The types of biopsy are fine needle, trocar, open incision or en bloc excision. There are advantages and disadvantages of each. Open biopsy requires strict adherence to a number of surgical principles. Proper execution requires determination of appropriate biopsy site, meticulous technique, and close collaboration with an experienced pathologist. Failure to adhere to these principles may result in untoward consequences for patients.
Language of Publication
English
Unique Identifier
93230764

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Biopsy|AE/IS/*MT; Sarcoma|DI/EP/*PA; Soft Tissue Neoplasms|DI/EP/*PA
MeSH Heading
Human; Magnetic Resonance Imaging; Neoplasm Seeding; Selection Bias; Sensitivity and Specificity; Tomography, X-Ray Computed; Tourniquets|ST; Wound Healing

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW LITERATURE
ISSN
0009-921X
Country of Publication
UNITED STATES

Record 13 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Does brachytherapy have a role in the treatment of prostate cancer?
Author
Grimm PD; Blasko JC; Ragde H; Sylvester J; Clarke D
Address
Tumor Institute Group of Seattle, Washington, USA.
Source
Hematol Oncol Clin North Am, 1996 Jun, 10:3, 653-73
Abstract
The goal of radiation therapy is to deliver a high dose to the tumor while preserving normal surrounding tissue. For early-stage prostate cancer, the ultimate conformal irradiation is to place radioactive sources directly into the gland either as permanent or temporary seeds. Permanent seed implantation is capable of delivering two times the radiobiologically equivalent dose of external beam irradiation to the prostate and tumor. In the past, the results of prostate brachytherapy were likely poor owing to the technical difficulty in accurately placing the radioactive seeds uniformly throughout the prostate. The use of low-dose-rate I-125 to treat high-grade cancers probably also contributed to the poorer results as compared with external beam irradiation. Over the last 10 years, however, technologic advances in transrectal ultrasonography, computer dosimetry, and template-based transperineal techniques have dramatically improved the accuracy and consistency of the brachytherapist to place radioactive sources directly into the prostate gland. Transperineal ultrasound or CT directed seed implantation has replaced the older retropubic method. Brachytherapists are now able to accurately map out the gland prior to the implant and carefully evaluate preoperatively seed placement. The availability of such radioactive sources as iodine-125, palladium-103, and iridium-192 has also given the brachytherapist isotopes that can be more carefully matched to the biology and stage of the tumor. More sensitive definitions of failure have prompted radiation oncologists and urologists to carefully evaluate the efficacy of external beam irradiation and surgery. Accurate comparison of the efficacy of brachytherapy to surgery and to external beam radiation requires a randomized study. Comparisons of retrospective studies are fraught with the problems of the heterogeneous nature of early-stage prostate cancer. Imbalances in stage, grade, initial PSA extraprostatic disease, and nodal status of patient groups make comparisons difficult. Most of the long-term data for permanent seed implantation are the result of work at a single institution. These results will need to be repeated at other institutions treating patients in a similar manner. Because techniques vary from institution to institution, permanent implant results will need to be carefully evaluated for technique as well as stratified for pretreatment variables. Pretreatment PSA and grade appear to be more sensitive variables than stage in predicting failure after radiation. As more patients are diagnosed with very early and nonpalpable disease, future studies will need to stratify patients based on these pretreatment factors. Patients with early-stage disease but identified as high risk for extraprostatic disease will require more intensive regimens. The treatment outcomes based on biopsy results are inconclusive. A lack of consensus on the definition of a truly positive biopsy remains forthcoming. The value of a positive prostate biopsy as an outcome predictor for clinical failure is still unclear. The use of prostate nuclear cell antigen staining may help clarify the issue. Comparison of treatment outcome based on absolute PSA is also difficult. The Seattle series suggest that brachytherapy by permanent seed implantation is as efficacious as external beam irradiation for early-stage disease in patients with a low PSA (< 10 ng/mL). As the PSA value rises above 10 ng/mL, the probability of failure after external beam rises substantially. Results from the Seattle series suggest an advantage to seed implant alone or the judicious application of seed implant boost to external beam radiation for these patients with more advanced cancer. The most sensitive measurement of therapeutic outcome is progression-free survival. Few studies to date have evaluated progression-free survival.
Language of Publication
English
Unique Identifier
96369497

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Prostatic Neoplasms|EC/PA/*RT
MeSH Heading
Biopsy; Brachytherapy|EC/MT; Cost-Benefit Analysis; Dose-Response Relationship, Radiation; Human; Male; Neoplasm Staging; Postoperative Care|MT; Treatment Outcome

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0889-8588
Country of Publication
UNITED STATES

Record 14 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Local control of prostate cancer with radiotherapy: frequency and prognostic significance of positive results of postirradiation prostate biopsy.
Author
Scardino PT; Wheeler TM
Address
Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030.
Source
NCI Monogr, 1988, :7, 95-103
Abstract
The best available data indicate that, although it is imperfect, the postirradiation biopsy performed at a sufficient interval after radiotherapy can provide accurate prognostic information useful in the determination of the success or failure of radiotherapy in an individual patient as well as the measurement of overall efficacy of any particular radiotherapeutic regimen. Needle biopsy of the prostate was performed routinely in 510 patients with clinical stage A2, B, or C1 prostate cancer treated with a combination of radioactive gold seed implantation and external-beam irradiation. Of the 140 patients who had one or more needle biopsies performed 6-36 months after completion of radiotherapy, who had no evidence of local recurrence or distant metastases at the time of biopsy, and who had received no hormonal therapy before documented recurrence of the tumor, 45 (32%) had one or more biopsies positive for cancer. The frequency of positive biopsy results correlated significantly with the size of the local tumor but not with the grade. The correlation between biopsy results and the eventual development of recurrence was highly significant. If any biopsy was positive, 60% of the patients eventually developed local recurrence; if all biopsies were negative, only 19% developed local recurrence during the period of follow-up. The poor prognosis associated with a positive biopsy result was found within almost every subset of stage, grade, or nodal status examined although the results varied because of the small number of patients in some groups.
Language of Publication
English
Unique Identifier
89014773

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Prostate|*PA; Prostatic Neoplasms|PA/*RT
MeSH Heading
Biopsy, Needle; Human; Male; Neoplasm Recurrence, Local; Prognosis

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW LITERATURE
ISSN
0893-2751
Country of Publication
UNITED STATES

Record 15 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Fine needle aspiration biopsy for diagnosis and follow-up of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
Author
Andersson L; Hagmar B; Ljung BM; Skoog L
Address
WHO Collaborating Centre for Urological Tumors, Karolinska Hospital, Stockholm, Sweden.
Source
Scand J Urol Nephrol Suppl, 1994, 162:, 43-9; discussion 115-27
Abstract
Fine needle aspiration biopsy (FNAB) and ultrasound-guided core biopsy using biopty gun both have a high, and approximately equal, accuracy in diagnosing and grading prostate cancer. The TRUS-guided technique provides a better estimation of the tumor extent and to some degree even of capsular involvement. It is therefore a recommendable part of the preoperative evaluation when radical prostatectomy is contemplated. On the other hand, the aspiration technique usually provides more epithelial cells. It entails a significantly lower risk of septic complications and of seeding tumor cells. It has also a lower cost than the core biopsies. The aspiration biopsy can easily be performed repeatedly in the follow-up procedure, which is of particular importance in cases managed with watchful waiting. We recommend the aspiration biopsy for routine use in the diagnostic work-up and follow-up. It is essential that not only the cytologic evaluation but as well the sampling from the prostate is performed with adequate expertise.
Language of Publication
English
Unique Identifier
95116885

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Biopsy, Needle|*/AE/EC; Prostate|*PA; Prostatic Neoplasms|*DI/*PA
MeSH Heading
Costs and Cost Analysis; Follow-Up Studies; Hemorrhage|ET; Human; Immunohistochemistry; Infection|ET; Male; Neoplasm Seeding; Prognosis; Referral and Consultation; Time Factors

Publication Type
CONSENSUS DEVELOPMENT CONFERENCE; JOURNAL ARTICLE; REVIEW
ISSN
0300-8886
Country of Publication
SWEDEN

Record 16 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Stereotactically guided needle biopsy of the breast for nonpalpable lesions.
Author
Harolds JA
Address
Baptist Medical Center of Oklahoma, Oklahoma City 73112.
Source
J Okla State Med Assoc, 1993 Dec, 86:12, 604-12
Abstract
Stereotactically guided needle biopsy of the breast is a new diagnostic technique in this country to obtain samples of a nonpalpable area deemed suspicious for malignancy on mammography. This article is a review of the literature, a report of a case, and a description of the technique. This procedure, when performed with a large core biopsy needle, appears to be about as accurate as surgical biopsy.
Language of Publication
English
Unique Identifier
94172481

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Biopsy, Needle|IS/*MT; Breast Neoplasms|*PA; Stereotaxic Techniques|*
MeSH Heading
Case Report; Clinical Protocols; Female; Human; Neoplasm Seeding

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
0030-1876
Country of Publication
UNITED STATES

Record 17 from database: MEDLINE
Return To Top
Return To Menu Position #10

Title
Perineal prostatic tumour seedling after 'Tru-Cut' needle biopsy: case report and review of the literature.
Author
Ryan PG; Peeling WB
Address
Department of Urology, St. Woolos Hospital, Newport, UK.
Source
Eur Urol, 1990, 17:2, 189-92
Abstract
The prostate gland is being biopsied increasingly frequently, especially as a result of the visualisation of suspect areas on transrectal ultrasonography, using a variety of different needle types. We report only the third case of tumour seedling in the tract following a transperineal biopsy of a prostatic cancer with a 'Tru-Cut' needle. The literature is reviewed with regard to the characteristics and the incidence of seedling and the importance of including the perineum in any treatment option is emphasized.
Language of Publication
English
Unique Identifier
90184178

Return To Top
Return To Menu Position #10


MeSH Heading (Major)
Biopsy, Needle|*AE; Neoplasm Seeding|*; Perineum|*; Prostate|*PA; Prostatic Neoplasms|*PA
MeSH Heading
Case Report; Human; Male; Middle Age; Needles

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
0302-2838
Country of Publication
SWITZERLAND

Record 18 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
Needle-track metastasis after transthoracic needle biopsy.
Author
Ayar D; Golla B; Lee JY; Nath H
Address
Department of Radiology, University of Alabama at Birmingham, 35233-6830, USA.
Source
J Thorac Imaging, 1998 Jan, 13:1, 2-6
Abstract
Metastasis along the needle track (NTM) after a transthoracic needle biopsy (TNB) is considered a very rare complication. A survey of the membership of the Society of Thoracic Radiology and a review of the English-language literature were conducted to assess the incidence of this complication and its predisposing factors and natural history. A questionnaire was sent to all radiology departments in the United States and Canada that had a senior member of the Society of Thoracic Radiology. The total number of TNB between 1978 and 1993 and occurrences of NTM were elicited. If an NTM was encountered, information on the size of the nodule, proximity to the pleura, histology, size of the biopsy needle, and the interval between biopsy and NTM and outcome of the patient was elicited. The incidence of NTM was estimated using binomial proportions. Results of the literature survey were tabulated to provide similar information. One hundred sixty-five questionnaires were mailed and 75 responses were received. Approximately 68,346 TNB were reported. Five departments reported a total of eight NTM, resulting in an incidence of 0.012%. The average interval between TNB and NTM was 2.6 months. There were no predictable risk factors. The outcome was known in only 11 patients; 4 patients died by the time of reporting (2 after 14 months and 1 each after 6 and 9 months). From the results of this survey, the incidence of NTM after TNB is approximately 0.012%. This small risk is random and unavoidable.
Language of Publication
English
Unique Identifier
98101781

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Biopsy, Needle|*AE; Neoplasm Seeding|*; Thoracic Neoplasms|*PA
MeSH Heading
Human; Incidence; Questionnaires

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
0883-5993
Country of Publication
UNITED STATES

Record 19 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
Wound implantation--A surgical hazard.
Author
Alagaratnam TT; Ong GB
Address
 
Source
Br J Surg, 1977 Dec, 64:12, 872-5
Abstract
A review of the literature on wound implantation together with a report on an unusual case of implantation of squamous carcinoma at the site of a gastrostomy is presented.
Language of Publication
English
Unique Identifier
78061586

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Neoplasm Seeding|*; Surgical Procedures, Operative|*AE
MeSH Heading
Biopsy; Carcinoma, Squamous Cell|ET; Case Report; Gastrostomy|AE; Human; Male; Middle Age; Neoplasm Metastasis; Stomach Neoplasms|ET; Tongue Neoplasms|SU

Publication Type
JOURNAL ARTICLE; REVIEW
ISSN
0007-1323
Country of Publication
ENGLAND

Record 20 from database: MEDLINE
Return To Top
Return To Menu Position #10
Return To Menu Position #20

Title
A review of tumours of the deep lobe of the parotid salivary gland.
Author
Carr RJ; Bowerman JE
Address
 
Source
Br J Oral Maxillofac Surg, 1986 Jun, 24:3, 155-68
Abstract
Tumours of the deep lobe of the parotid gland may present as a swelling in the oropharynx. They are uncommon when compared with those of the superficial lobe, are frequently misdiagnosed and subjected to per-oral biopsy which is hazardous and predisposes to seeding of the tumour. Investigation and diagnosis are discussed with particular reference to the role of computed tomography. The surgical approach to these inaccessible tumours is illustrated by reference to patients treated. Modifications to the technique of Cooke and Ranger (1969) for excision of parapharyngeal tumours are suggested, which are applicable to tumours of the deep lobe extending medial to the mandible and presenting in the side wall of the pharynx.
Language of Publication
English
Unique Identifier
86243254

Return To Top
Return To Menu Position #10
Return To Menu Position #20


MeSH Heading (Major)
Parotid Gland|AH/*PA/SU; Parotid Neoplasms|DI/*PA/SU
MeSH Heading
Adenoma, Pleomorphic|PA/SU; Adult; Biopsy; Case Report; Diagnosis, Differential; Female; Human; Male; Osteotomy; Palpation; Tomography, X-Ray Computed

Publication Type
JOURNAL ARTICLE; REVIEW
ISSN
0266-4356
Country of Publication
SCOTLAND

Record 21 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Liver abscesses due to Staphylococcus aureus in a patient with AIDS who underwent small bowel biopsy: case report and review.
Author
Gunnarsson G; Friedman LS; Wanke C
Address
Division of Infectious Diseases, New England Deaconess Hospital, Boston, Massachusetts 02215.
Source
Clin Infect Dis, 1994 May, 18:5, 802-4
Abstract
A 36-year-old man with overgrowth of Staphylococcus aureus in the small bowel underwent a biopsy of the small bowel and presented 5 weeks later with multiple liver abscesses. To our knowledge, small bowel biopsy has never been associated with liver abscesses. We discuss the literature on liver abscesses in patients with AIDS and the risks of bacteremia following upper endoscopy and small bowel biopsy and propose that the etiology of the liver abscesses in our patient was seeding of the portal vein following biopsy of a small bowel that had significant bacterial overgrowth.
Language of Publication
English
Unique Identifier
94355517

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
AIDS-Related Opportunistic Infections|ET/*MI/PS; Biopsy|*AE; Duodenoscopy|*AE; Duodenum|*PA; Liver Abscess|ET/*MI; Staphylococcal Infections|*/ET
MeSH Heading
Adult; Case Report; Cryptosporidiosis|CO/DI; Diarrhea|CO/DI; Duodenitis|CO/DI/PA; Fatal Outcome; Human; Intestinal Diseases, Parasitic|CO/DI/PA; Male; Portal Vein

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
1058-4838
Country of Publication
UNITED STATES

Record 22 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Laparoscopic management of cancer patients.
Author
Cuschieri A
Address
Department of Surgery, Ninewells Hospital and Medical School, Dundee, UK.
Source
J R Coll Surg Edinb, 1995 Feb, 40:1, 1-9
Abstract
All the reported experience indicates that laparoscopic staging of tumours provides additional information to the preoperative work-up. Its diagnostic yield is enhanced by contact ultrasonography. Staging laparoscopy may avoid needless laparotomy and permits palliative surgical treatment, bypass and resection. The major controversy concerns laparoscopic ablative procedure for potentially curative cancer in view of the potential but unproved risk of tumour dissemination and inadequate resection. Until further information becomes available from experimental investigations and centralized clinical studies, laparoscopic curative resections should not be performed routinely. Laparoscopic or retroperitoneoscopic lymphadenectomy appears to be useful by documenting node positive disease. Laparoscopic hepatic cryotherapy with insulated needle probes has the potential for control of secondary hepatic disease not amenable to surgical resection.
Language of Publication
English
Unique Identifier
95257227

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Laparoscopy|*; Neoplasms|*PA/*SU/TH; Surgical Procedures, Laparoscopic|*/AE
MeSH Heading
Biliary Tract Neoplasms|PA/SU; Biopsy; Cryotherapy; Gastrointestinal Neoplasms|PA/SU; Human; Liver Neoplasms|PA/SU; Lymph Node Excision; Neoplasm Seeding; Palliative Care

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0035-8835
Country of Publication
ENGLAND

Record 23 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Subcutaneous metastasis following laparoscopy in gastric adenocarcinoma.
Author
Cava A; Román J; González Quintela A; Martín F; Aramburo P
Address
Servicio de OncologÆia MÆedica, ClÆinica Puerta de Hierro, Madrid, Spain.
Source
Eur J Surg Oncol, 1990 Feb, 16:1, 63-7
Abstract
An 80-year-old male developed ascites as the first indication of an adenocarcinoma of the gastroesophageal junction. Laparoscopy was performed during the diagnostic study of the ascites and, 7 days later at the point of introduction of the laparoscope, a metastasis developed in skin and subcutaneous cellular tissue. This is the third case of subcutaneous neoplastic implantation following laparoscopy to appear in the literature. The two previously described cases dealt with patients with ovarian adenocarcinoma. The literature reporting cases of tumor dissemination following technical procedures is reviewed.
Language of Publication
English
Unique Identifier
90169148

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Adenocarcinoma, Mucinous|DI/PA/*SC; Laparoscopy|*AE; Neoplasm Seeding|*; Skin Neoplasms|PA/*SC; Stomach Neoplasms|DI/*PA
MeSH Heading
Abdominal Muscles|PA; Aged; Aged, 80 and over; Biopsy; Case Report; Esophagogastric Junction; Human; Male

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
0748-7983
Country of Publication
ENGLAND

Record 24 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Detailed preliminary analysis of 125iodine implantation for localized prostate cancer using percutaneous approach.
Author
Kaye KW; Olson DJ; Payne JT
Address
Department of Urology, Abbott Northwestern Hospital, Minneapolis, Minnesota.
Source
J Urol, 1995 Mar, 153:3 Pt 2, 1020-5
Abstract
Recent developments have permitted accurate seed placement and dosimetry for interstitial brachytherapy of selected patients with localized prostate cancer. We present our experience with 76 patients divided into 2 groups. Group 1 included 45 patients with smaller, more well differentiated tumors, usually less than 2 cm. in diameter on digital rectal examination or transrectal ultrasound and a Gleason score of less than 7 who were treated with 125iodine alone. Group 2 consisted of 31 patients with localized tumors greater than 2 cm. in diameter and/or a Gleason sum equal to or greater than 7 who were treated with low dose external beam radiation followed by 125iodine boost 4 weeks later. Complete clinical progression-free survival, including prostate specific antigen, digital rectal examination and biopsy, was 51% for group 1 and 63.3% for group 2, with a mean followup of 26.3 months. Prostate specific antigen progression-free survival was 97.7% for group 1 and 94.7% for group 2. These results appear to be superior to external beam radiation only although longer followup is needed to substantiate these favorable early results. The procedures were well tolerated with good potency sparing. They were performed on an outpatient or short stay basis and provided a good alternative to external beam radiation only or hormonal treatment for select patients with localized prostate cancer who may not be candidates for radical prostatectomy.
Language of Publication
English
Unique Identifier
95156646

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Brachytherapy|AE/*MT; Iodine Radioisotopes|*TU; Prostatic Neoplasms|BL/MO/PA/*RT
MeSH Heading
Aged; Aged, 80 and over; Biopsy; Combined Modality Therapy; Comparative Study; Follow-Up Studies; Human; Male; Middle Age; Prostate-Specific Antigen|BL; Support, Non-U.S. Gov't; Survival Rate

Publication Type
CLINICAL TRIAL; JOURNAL ARTICLE; REVIEW; REVIEW, MULTICASE
ISSN
0022-5347
Country of Publication
UNITED STATES

Record 25 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Surgical management of conjunctival tumors. The 1994 Lynn B. McMahan Lecture.
Author
Shields JA; Shields CL; De Potter P
Address
Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pa, USA.
Source
Arch Ophthalmol, 1997 Jun, 115:6, 808-15
Abstract
To our knowledge, there are no articles that describe the specific step-by-step details of the surgical removal of premalignant and malignant conjunctival tumors. We describe our current approach to the surgical management of squamous cell carcinoma (intraepithelial or invasive), localized melanoma, and primary acquired melanosis of the conjunctiva. The surgical method differs with limbal tumors, extralimbal tumors, and primary acquired melanosis. Limbal lesions are managed by localized alcohol corneal epitheliectomy, removal of the main mass by a partial lamellar scleroconjunctivectomy, and supplemental cryotherapy. Tumors located in the extralimbal conjunctiva are managed by alcohol application, wide circumferential surgical resection, and cryotherapy. Primary acquired melanosis is managed by alcohol epitheliectomy, removal of suspicious foci, quadrantic staging biopsies, and cryotherapy from the underside of the conjunctiva. In all cases, a "no touch" method is used and direct manipulation of the tumor is avoided to prevent tumor cell seeding into a new area. We have employed this technique on 109 patients with conjunctival squamous neoplasms and 137 patients with conjunctival melanoma, about 80 of which neoplasms were associated with primary acquired melanosis. Our observations suggest that well-planned initial surgical management using this technique decreases the chance of tumor recurrence for conjunctival melanoma and squamous cell carcinoma. We describe a detailed stepwise approach to the surgical management of conjunctival neoplasms. It requires meticulous clinical evaluation and complete removal of the tumor in one operation using a specific technique.
Language of Publication
English
Unique Identifier
97338179

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Conjunctival Neoplasms|PA/*SU
MeSH Heading
Anesthesia, Local; Biopsy; Human; Medical Illustration; Melanosis|SU; Neoplasm Staging; Support, Non-U.S. Gov't

Publication Type
LECTURES; REVIEW; REVIEW, TUTORIAL
ISSN
0003-9950
Country of Publication
UNITED STATES

Record 26 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Scrofuloderma of the lower extremity treated with wide resection: a case report and review of the literature.
Author
Connolly B; Pitcher JD Jr; Roth B; Youngberg RA; Devine J
Address
Department of Orthopaedic Surgery, Madigan Army Medical Center, Tacoma, Washington, USA.
Source
Am J Orthop, 1999 Jul, 28:7, 417-20
Abstract
Scrofuloderma is tuberculosis of subcutaneous tissue that ulcerates and drains through the overlying skin. It most commonly occurs in the neck from a cervical lymph node source. Although such lymphatic spread is the usual clinical picture, there are sporadic reports in the literature of direct hematogenous seeding of subcutaneous tissue forming a tuberculoma, or "cold abscess." Definitive diagnosis requires the identification of Mycobacterium tuberculosis within the suspect lesion. Surgical intervention is necessary in any draining lesion and should be accompanied by appropriate antituberculous chemotherapy. Accounts of bone and joint involvement are numerous, but the orthopedic surgeon must also be aware of the soft-tissue manifestations of tuberculosis and the indications for surgery. We report on an immunocompromised patient who presented with a rare case of scrofuloderma of the lower extremity, which was treated with wide resection.
Language of Publication
English
Unique Identifier
99353484

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Mycobacterium tuberculosis|*IP; Tuberculosis, Cutaneous|DI/DT/*PA/*SU
MeSH Heading
Adult; Antitubercular Agents|TU; Biopsy, Needle; Case Report; Female; Follow-Up Studies; Human; Leg|SU; Magnetic Resonance Imaging; Orthopedic Procedures|MT; Tomography, X-Ray Computed; Treatment Outcome

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
1078-4519
Country of Publication
UNITED STATES

Record 27 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer.
Author
Nag S; Beyer D; Friedland J; Grimm P; Nath R
Address
Prostate Brachytherapy Quality Assurance Group, Clinical Research Committee, American Brachytherapy Society, Reston, VA, USA. nag.1@osu.edu
Source
Int J Radiat Oncol Biol Phys, 1999 Jul, 44:4, 789-99
Abstract
PURPOSE/OBJECTIVE: To develop and disseminate the American Brachytherapy Society (ABS) recommendations for the clinical quality assurance and guidelines of permanent transperineal prostate brachytherapy with 125I or 103Pd. METHODS AND MATERIALS: The ABS formed a committee of experts in prostate brachytherapy to develop consensus guidelines through a critical analysis of published data supplemented by their clinical experience. The recommendations of the panels were reviewed and approved by the Board of Directors of the ABS. RESULTS: Patients with high probability of organ-confined disease are appropriately treated with brachytherapy alone. Brachytherapy candidates with a significant risk of extraprostatic extension should be treated with supplemental external beam radiation therapy (EBRT). Patient selection guidelines were developed. Dosimetric planning of the implant should be carried out for all patients before seed insertion. A modified peripheral loading is preferred. The AAPM TG-43 recommendations requiring a change in prescription dose for 125I sources should be universally implemented. The recommended prescription doses for monotherapy are 145 Gy for 125I and 115-120 Gy for 103Pd. The corresponding boost doses (after 40-50 Gy EBRT) are 100-110 Gy and 80-90 Gy, respectively. Clinical evidence to guide selection of radionuclide (103Pd or 125I) is lacking. Post implant dosimetry and evaluation must be performed on all patients. It is suggested that the dose that covers 90% (D90) and 100% (D100) of the prostate volume and the percentage of the prostate volume receiving the prescribed dose (V100) be obtained from a dose-volume histogram (DVH) and reported. CONCLUSION: Guidelines for appropriate patient selection, dose reporting, and improved quality of permanent prostate brachytherapy are presented. These broad recommendations are intended to be technical and advisory in nature, but the ultimate responsibility for the medical decisions rests with the treating physician. This is a constantly evolving field, and the recommendations are subject to modifications as new data becomes available.
Language of Publication
English
Unique Identifier
99313206

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Brachytherapy|*MT/ST; Prostatic Neoplasms|PA/*RT
MeSH Heading
Biopsy; Human; Iodine Radioisotopes|TU; Male; Palladium|TU; Patient Selection; Postoperative Care; Quality Assurance, Health Care; Radioisotopes|TU; Radiopharmaceuticals|TU; Radiotherapy Dosage; United States

Publication Type
GUIDELINE; JOURNAL ARTICLE; PRACTICE GUIDELINE; REVIEW; REVIEW LITERATURE
ISSN
0360-3016
Country of Publication
UNITED STATES

Record 28 from database: MEDLINE
Return To Top
Return To Menu Position #20

Title
Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
Author
Soloway MS; Jordan AM; Murphy WM
Address
Department of Urology, University of Tennessee, Memphis.
Source
Prog Clin Biol Res, 1989, 310:, 215-36
Abstract
1. A thorough evaluation of the urinary tract is an integral part of the initial management of a patient with transitional cell carcinoma. The site of all urothelial abnormalities must be determined and adequate histologic material obtained and reviewed. The urothelium not involved by obvious tumor should also be evaluated by either cytology or mucosal biopsies. All patients with high grade tumor should have a biopsy from the prostatic urethra. 2. The clinician should determine the risk of progression by evaluating the tumor grade, stage, and the presence or absence of carcinoma in situ. 3. The likelihood of a recurrence following endoscopic resection of a superficial bladder tumor ranges from 20% for a solitary low grade tumor to over 90% for a patient with multifocal high grade cancer. 4. The reasons for the high incidence of a subsequent tumor include new occurrences related to the continued contact of carcinogens with the susceptible urothelium, failure to completely resect all tumor, and possibly the implantation of tumor cells on the altered urothelial surface following endoscopic resection. 5. Intravesical instillation of antineoplastic agents is capable of reducing the incidence of a subsequent tumor when used for prophylaxis. These agents are also capable of eradicating residual tumor. 6. The clinician should determine whether intravesical therapy is being used for treatment or prophylaxis. 7. Thiotepa is a relatively inexpensive and safe intravesical chemotherapeutic agent which, when used for treatment of existing tumor, will provide a complete response rate of from 35 to 45%. There is a suggestion that it is more effective in low grade than high grade tumors. Prospective randomized trials indicate that patients receiving Thiotepa are less likely to develop a subsequent tumor in a given period of time than patients who do not receive intravesical therapy. 8. Mitomycin-C will provide a complete response rate in high risk patients from 35 to 50% when used for treatment of existing tumor. Approximately 15% of such patients will progress to muscle invasion if followed for approximately three years. There are few randomized trials using Mitomycin-C to determine its efficacy for prophylaxis. 9. BCG has been used for treatment and prophylaxis of superficial bladder cancer. It is relatively inexpensive. The side effects vary with the strain. Several strains have been used but they have not been compared in randomized trials. When used for treatment, the complete response rate ranges from 50 to 65%.(ABSTRACT TRUNCATED AT 400 WORDS)
Language of Publication
English
Unique Identifier
89367401

Return To Top
Return To Menu Position #20


MeSH Heading (Major)
Antineoplastic Agents|AD/*TU; Bladder Neoplasms|*DT/PC/TH; Carcinoma, Transitional Cell|*DT/PC/TH
MeSH Heading
Administration, Intravesical; BCG Vaccine|TU; Carcinoma in Situ|DT/PA; Doxorubicin|TU; Human; Mitomycins|TU; Neoplasm Recurrence, Local; Neoplasm Seeding; Thiotepa|TU

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0361-7742
Country of Publication
UNITED STATES

Record 29 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
An interpretive review of lymphoma of the stomach.
Author
Hertzer NR; Hoerr SO
Address
 
Source
Surg Gynecol Obstet, 1976 Jul, 143:1, 113-24
Abstract
Lymphoma of the stomach may exist as a primary lesion or as a manifestation of generalized or systemic lymphoma. The primary lesions constitute approximately 3 per cent of all malignant lesions of the stomach and outnumber all other types of non-epithelial malignant lesions. The cause is not known. Gross characteristics often resemble carcinoma, and like carcinoma, the primary lesion may affect other structures by direct extension, may seed to peritoneal surfaces, may metastasize to lymph nodes near or far, and may be borne by the blood to liver, lung or bone. Diagnosis begins with clinical suspicion by the physician, is supported by the results of roentogenographic and gastroscopic studies, and is finally established by a positive study of biopsy specimens obtained with or without laparotomy. Improvements in both gastroscopic instruments and their use promise to increase greatly the accuracy of preoperative diagnosis. Pseudolymphoma of the stomach, a rare type of inflammatory lesion, may, on occasion, offer a difficult differential diagnosis from that of lymphoma. The clinical approach to the lesion, whether the diagnosis is histologically proved or not, is the same as for suspected carcinoma. A laparotomy is usually necessary to determine the possibility of surgical cure, unless distant spread or systemic involvement can be established by other means, such as a distant lymph node containing the disease or a positive needle biopsy of the liver. When a cure seems possible, resection is favored by most surgeons, even though it entails total gastrectomy or multiple organ resection. Opinion is divided as to whether or not a curative resection should be followed routinely by irradiation, although irradiation is generally favored by palliation of lesions not amenable to resection. Transgastroscopic biopsy and gastroscopic follow-up study may permit radiation to be tested as the only form of treatment of favorable lesions. At the present time, chemotherapy should be reserved for lesions not controlled by operation or irradiation. Stage for stage, the outlook for lymphoma of the stomach is about twice as favorable as that for carcinoma. No generally accepted classification of lymphoma exists as yet. Correlations between prognosis and microscopic characteristics are not close, except for the generally favorable outlook for lymphocytic lymphoma.
Language of Publication
English
Unique Identifier
76224788

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Lymphoma|*/DI/EP/ET/PA/TH; Stomach Neoplasms|*/DI/EP/ET/PA/TH
MeSH Heading
Demography; Gastric Juice; Human; Lymphatic Metastasis; Sarcoma|EP; Stomach Ulcer|CO

Publication Type
JOURNAL ARTICLE; REVIEW
ISSN
0039-6087
Country of Publication
UNITED STATES

Record 30 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
Extraneural metastases of astrocytomas and glioblastomas: clinicopathological study of two cases and review of literature.
Author
Pasquier B; Pasquier D; NGolet A; Panh MH; Couderc P
Address
 
Source
Cancer, 1980 Jan, 45:1, 112-25
Abstract
Two cases of intracranial gliomas with extraneural metastases are described. Case 1, studied with biopsy material only, was a left malignant astrocytoma from the area of the rolandic fissure with right cervical lymph nodes metastases in a 43-year-old man. Case 2 was a left temporal malignant astrocytoma in a 21-year-old woman. Fifteen days after craniotomy, a left submandibular lymph node metastasis appeared. Forty days after surgery, a ventriculoperitoneal shunt was performed. Fifty-four days after surgery, the patient died. Autopsy revealed three liver metastases. Our review of the literature consists of 72 autopsy cases with extraneural deposits. Thos metastases occurred mainly in adults (63/72) and among men (46/72). The primary glioma was supratentorial in 67 cases. Metastases were mainly pulmonary and pleural. The majority of patients (82.8%) died within 2 years after onset of symptoms. In 8 of the cases, metastasis developed without any craniotomy and in 8 other cases, through a shunt.
Language of Publication
English
Unique Identifier
80089716

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Astrocytoma|PA/*SC; Brain Neoplasms|*; Glioma|PA/*SC; Meningeal Neoplasms|PA/*SC
MeSH Heading
Adolescence; Adult; Aged; Case Report; Child; Female; Human; Lymphatic Metastasis|PA; Male; Middle Age; Neoplasm Seeding

Publication Type
JOURNAL ARTICLE; REVIEW
ISSN
0008-543X
Country of Publication
UNITED STATES

Record 31 from database: MEDLINE
Return To Top
Return To Menu Position #20
Return To Menu Position #30

Title
Port site recurrences after laparoscopic and thoracoscopic procedures in malignancy.
Author
Johnstone PA; Rohde DC; Swartz SE; Fetter JE; Wexner SD
Address
Clinical Investigations Department, Naval Medical Center, San Diego, CA 92134-5000, USA. pajohnst@snd10.med.navy.mil
Source
J Clin Oncol, 1996 Jun, 14:6, 1950-6
Abstract
PURPOSE AND METHODS: A review of the literature was performed to determine the number of cases of port site recurrences (PSR) after laparoscopy or thoracoscopy. CANCERLINE and MEDLINE were searched, as were citings from retrieved and related papers. RESULTS: There have been 35 reported cases of PSR after laparoscopic colectomy for colorectal carcinoma, and 23 cases after thoracoscopic procedures for lung neoplasms. All of these have been reported since 1993. Since 1991, 12 cases have been described after laparoscopic cholecystectomy of unsuspected gallbladder carcinoma, and another case after biopsy of a known gallbladder carcinoma. Ten cases of PSR have been reported after laparoscopic procedures for ovarian lesions, often in the presence of peritoneal seeding at diagnosis. Other rare PSRs have been documented after several procedures in various malignancies. CONCLUSION: Enrollment of patients onto the ongoing intergroup study evaluating open versus laparoscopic resection of colon cancer should be encouraged. Until valid prospective data on PSR frequency are available, laparoscopic or thoracoscopic resection of malignancy off-protocol should be undertaken with circumspection.
Language of Publication
English
Unique Identifier
96243755

Return To Top
Return To Menu Position #20
Return To Menu Position #30


MeSH Heading (Major)
Laparoscopy|*AE; Neoplasm Seeding|*; Thoracoscopy|*AE
MeSH Heading
Colorectal Neoplasms|SU; Human; Lung Neoplasms|SU; Punctures|AE; Support, U.S. Gov't, Non-P.H.S.

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, MULTICASE
ISSN
0732-183X
Country of Publication
UNITED STATES

Record 32 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Extracranial osseous metastases from intracranial meningioma.
Author
Palmer JD; Cook PL; Ellison DW
Address
Department of Neurosurgery, Wessex Neurological Centre, Southampton General Hospital, UK.
Source
Br J Neurosurg, 1994, 8:2, 215-8
Abstract
A biopsy of a fifth lumbar vertebral lesion confirmed that an intracranial meningioma had metastasized 12 years after the diagnosis of the primary tumour. A literature review reports 25 cases of extracranial osseous metastases from meningioma. The mechanisms of spread are discussed as is the role of surgery in the seeding of such tumours.
Language of Publication
English
Unique Identifier
95000380

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Lumbar Vertebrae|PA/*SU; Meningeal Neoplasms|PA/*SU; Meningioma|PA/*SC/SU; Spinal Neoplasms|PA/*SC/SU
MeSH Heading
Case Report; Craniotomy; Human; Male; Middle Age; Neoplasm Recurrence, Local|PA/SU; Neoplasm Seeding

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
0268-8697
Country of Publication
ENGLAND

Record 33 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Food allergy in atopic dogs.
Author
Frick OL
Address
University of California, San Francisco, USA.
Source
Adv Exp Med Biol, 1996, 409:, 1-7
Abstract
The food sensitive dog provides a good animal model for food allergy, whose allergic reaction can be followed serially with repeated challenges both in skin and by oral challenges and by endoscopic direct visualization and serial biopsies. This model is proving useful in showing reduced allergenicity in food allergens-soy, wheat, cow's milk by thioredoxin treatment. Recently Dr. Buchanan has cloned the gene for the NADP-thioredoxin reductase (NTR) which he transferred into barley seeds with a bacterial vector. He is attempting to do the same with wheat and soy seeds to produce genetically hypoallergenic foods. The canine model for food allergy provides an excellent model in which to test such bio-engineered potentially hypoallergenic foods.
Language of Publication
English
Unique Identifier
97249330

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Food Hypersensitivity|*; Models, Immunological|*
MeSH Heading
Animal; Dogs

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0065-2598
Country of Publication
UNITED STATES

Record 34 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Surgical management of cancer.
Author
Henderson RA; Swaim SF; Hankes GH
Address
 
Source
Mod Vet Pract, 1984 Aug, 65:8, 615-21
Abstract
In cancer surgery, operating time, tissue trauma and other stress should be minimized because circulating dormant tumor cells may be reactivated by stress, including that of anesthesia. Rectal polyps and Sertoli-cell tumors should be removed as soon after diagnosis as possible. Neutering is recommended to reduce the risk of certain tumors. Biopsies should contain tissue from the center and periphery of the lesion. Laparotomy or thoracotomy may be necessary to visually inspect internal tumors. Debulking or partial resection of large tumors may render them more susceptible to chemotherapy or irradiation. Palliative surgery may be desirable to comfortably prolong an animal's life. In curative surgery, enlarged local lymph nodes should also be resected, hemorrhage controlled and lavage used to prevent tumor-cell seeding. Complete resection should take precedence over reconstructing the defect created by resection.
Language of Publication
English
Unique Identifier
85036217

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Neoplasms|PA/SU/*VE
MeSH Heading
Animal; Human; Palliative Care; Precancerous Conditions|SU/VE

Publication Type
JOURNAL ARTICLE; REVIEW
ISSN
0362-8140
Country of Publication
UNITED STATES

Record 35 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Testis risk and prognostic factors. The pathologist's perspective.
Author
Ulbright TM
Address
Department of Pathology, Indiana University School of Medicine, Indianapolis, USA.
Source
Urol Clin North Am, 1999 Aug, 26:3, 611-26
Abstract
Pathologic analysis is invaluable in defining the levels of risk for the development of a testicular tumor or for metastasis in a patient with an established testicular cancer. The identification of IGCNU in testicular biopsies defines a group of patients at high risk for subsequent invasive germ cell tumor unless they are treated by orchiectomy or radiotherapy. This method for defining the risk for the development of a testicular tumor is not effective in prepubertal patients, except for those with intersex syndromes. Pathologic analysis of testicular germ cell tumors in patients with clinical stage I disease may allow their stratification into high- and low-risk groups for occult metastases. This would provide a rational basis for recommending intervention or surveillance, respectively. The precise classification of postchemotherapy lesions permits an assessment of the patient's risk for subsequent recurrence and progressive tumor.
Language of Publication
English
Unique Identifier
99424079

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Testicular Neoplasms|DT/*ET/*PA/SU
MeSH Heading
Antineoplastic Agents|TU; Human; Male; Neoplasm Seeding; Orchiectomy|AE; Prognosis; Risk; Risk Factors

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
0094-0143
Country of Publication
UNITED STATES

Record 36 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Nonresective treatment of pineoblastoma: a case report.
Author
Patil AA; Good R; Bashir R; Etemadrezaie H
Address
Division of Neurosurgery, University of Nebraska Medical Center, Omaha 68918-2035, USA.
Source
Surg Neurol, 1995 Oct, 44:4, 386-903; discussion 390-1
Abstract
BACKGROUND: Stereotactic biopsy followed by cytoreductive surgery and/or radiation are the standard treatment for pineoblastoma. We are reporting a patient with a relatively large pineoblastoma, who was treated with a combination of nonresective treatment modalities. METHOD: The patient is a 20-year-old woman who presented with signs and symptoms of raised intracranial pressure. Magnetic resonance imaging (MRI) showed a large tumor in the pineal region and hydrocephalus. She was emergently treated by placement of a ventriculoperitoneal shunt. Three days later she underwent a stereotactic biopsy, which showed the tumor to be pineoblastoma. She was then further treated with the following treatment modalities: permanent implantation of high activity I125 seeds, external radiation, and chemotherapy. RESULTS: At 10 months' follow-up, MRI showed complete disappearance of the tumor. At 18 months' follow-up, the patient is asymptomatic, neurologically intact, and her MRI scans show no evidence of intracranial or intraspinal tumor. CONCLUSIONS: Though the follow-up is relatively short, the results of the nonresective approach in this patient have been excellent.
Language of Publication
English
Unique Identifier
96149528

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Brain Neoplasms|DI/*DT/*RT; Pineal Body|*/PA; Pinealoma|DI/*DT/*RT
MeSH Heading
Adult; Brachytherapy|MT; Case Report; Chemotherapy, Adjuvant; Female; Human; Iodine Radioisotopes|TU; Magnetic Resonance Imaging; Radiotherapy, Adjuvant

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
0090-3019
Country of Publication
UNITED STATES

Record 37 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
A comprehensive review of prostate cancer brachytherapy: defining an optimal technique.
Author
Vicini FA; Kini VR; Edmundson G; Gustafson GS; Stromberg J; Martinez A
Address
Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI 48073, USA.
Source
Int J Radiat Oncol Biol Phys, 1999 Jun, 44:3, 483-91
Abstract
PURPOSE: A comprehensive review of prostate cancer brachytherapy literature was performed to determine if an optimal method of implantation could be identified, and to compare and contrast techniques currently in use. METHODS AND MATERIALS: A MEDLINE search was conducted to obtain all articles in the English language on prostate cancer brachytherapy from 1985 through 1998. Articles were reviewed and grouped to determine the primary technique of implantation, the method or philosophy of source placement and/or dose specification, the technique to evaluate implant quality, overall treatment results (based upon pretreatment prostate specific antigen, (PSA), and biochemical control) and clinical, pathological or biochemical outcome based upon implant quality. RESULTS: A total of 178 articles were identified in the MEDLINE database. Of these, 53 studies discussed evaluable techniques of implantation and were used for this analysis. Of these studies, 52% used preoperative ultrasound to determine the target volume to be implanted, 16% used preoperative computerized tomography (CT) scans, and 18% placed seeds with an open surgical technique. An additional 11% of studies placed seeds or needles under ultrasound guidance using interactive real-time dosimetry. The number and distribution of radioactive sources to be implanted or the method used to prescribe dose was determined using nomograms in 27% of studies, a least squares optimization technique in 11%, or not stated in 35%. In the remaining 26%, sources were described as either uniformly, differentially, or peripherally placed in the gland. To evaluate implant quality, 28% of studies calculated some type of dose-volume histogram, 21% calculated the matched peripheral dose, 19% the minimum peripheral dose, 14% used some type of CT-based qualitative review and, in 18% of studies, no implant quality evaluation was mentioned. Six studies correlated outcome with implant dose. One study showed an association of implant dose with the achievement of a PSA nadir < or = 0.5. Two studies showed an improvement in biochemical control with a D90 (dose to 90% of the prostate volume) of 120 to 140 Gy or higher, and 2 additional studies found an association of clinical outcome with implant dose. One study correlated implant quality with biopsy results. Of the articles, 33 discussed evaluable treatment results, but only 16 reported findings based upon pretreatment PSA and biochemical control. Three- to 5-year biochemical control rates ranged from 48% to 100% for pretreatment PSAs < or = 4, 55% to 90% for PSAs between 4 and 10, 30% to 89% for PSAs > 10, < or = 20 and < 10% to 100% for PSAs > 20. Due to substantial differences in patient selection criteria (e.g., median Gleason score, clinical stage, pretreatment PSA), number of patients treated, median follow-up, definitions of biochemical control, and time points for analysis, no single technique consistently produced superior results. CONCLUSIONS: Our comprehensive review of prostate cancer brachytherapy literature failed to identify an optimal treatment approach when studies were analyzed for treatment outcome based upon pretreatment PSA and biochemical control. Although several well-designed studies showed an improvement in outcome with total dose or implant quality, the numerous techniques for implantation and the varied and inconsistent methods to specify dose or evaluate implant quality suggest that standardized protocols should be developed to objectively evaluate this treatment approach. These protocols have recently been suggested and, when implemented, should significantly improve the reporting of treatment data and, ultimately, the efficacy of prostate brachytherapy.
Language of Publication
English
Unique Identifier
99276031

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Brachytherapy|*MT/ST; Prostatic Neoplasms|BL/*RT
MeSH Heading
Dose-Response Relationship, Radiation; Human; Male; Prostate-Specific Antigen|BL; Radiopharmaceuticals|TU; Radiotherapy Dosage; Treatment Outcome

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW LITERATURE
ISSN
0360-3016
Country of Publication
UNITED STATES

Record 38 from database: MEDLINE
Return To Top
Return To Menu Position #30

Title
Bone metastasis associated with shunt-related peritoneal deposits from a pineal germinoma. Case report and review of the literature.
Author
Pallini R; Bozzini V; Scerrati M; Zuppi C; Zappacosta B; Rossi GF
Address
Institute of Neurosurgery, Catholic University School of Medicine, Rome, Italy.
Source
Acta Neurochir (Wien), 1991, 109:1-2, 78-83
Abstract
The case of a 15-year-old boy with a pineal germinoma is reported. The patient first underwent a ventriculoperitoneal (VP) shunt followed by a stereotactic biopsy, then, because of the rapidly deteriorating neurological status, an emergency craniotomy with subtotal removal of the tumour was performed. Two months after surgery, a left femoral metastasis and extensive peritoneal lesions became evident; they were regarded as due to haematogenous and VP shunt spread of the germinoma. At that time, extremely high serum levels of placental alkaline phosphatase were detected. The patient died 6 months after the initial diagnosis. The occurrence of extraneural metastases as well as of shunt related peritoneal deposits from primary intracranial germinoma is discussed. As far as we know this is the first reported case of a combination of haematogenous as well as VP shunt spread of a pineal germinoma.
Language of Publication
English
Unique Identifier
91298095

Return To Top
Return To Menu Position #30


MeSH Heading (Major)
Brain Neoplasms|*PA; Cerebrospinal Fluid Shunts|*; Femoral Neoplasms|PA/*SC; Hydrocephalus|PA/*SU; Peritoneal Neoplasms|PA/*SC; Pineal Body|*PA; Pinealoma|PA/*SC; Postoperative Complications|*PA
MeSH Heading
Adolescence; Case Report; Femur|PA; Human; Male; Neoplasm Seeding; Peritoneum|PA; Support, Non-U.S. Gov't

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
0001-6268
Country of Publication
AUSTRIA

Record 39 from database: MEDLINE
Return To Top
Return To Menu Position #30
Return To Menu Position #40

Title
Leukemic dermal infiltrate at the exit site of a central venous catheter.
Author
Martino R; Sureda A; Sitjas D; Nomdedéu J; Domingo Albòs A
Address
Department of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Source
Haematologica, 1993 Mar, 78:2, 132-4
Abstract
This report describes the case of a minimally differentiated acute myeloid leukemia (FAB M0) diagnosed in a 55-year-old woman. During a second chemotherapy-induced complete remission, a subcutaneous nodule appeared at the scar of a recently removed Hickman catheter, which when biopsied revealed leukemic infiltration of the dermis and hypodermis. The patient had a bone marrow relapse three weeks later. The authors review similar recent reports and emphasize the importance of recognizing this particular type of cutaneous leukemic relapse.
Language of Publication
English
Unique Identifier
93351956

Return To Top
Return To Menu Position #30
Return To Menu Position #40


MeSH Heading (Major)
Catheterization, Central Venous|*AE; Leukemia, Myeloid|DT/*PA; Neoplasm Seeding|*; Skin|*PA
MeSH Heading
Acute Disease; Amsacrine|AD; Antineoplastic Agents, Combined|AD/TU; Bone Marrow|PA; Case Report; Cyclophosphamide|AD; Cytarabine|AD; Daunorubicin|AD; Etoposide|AD; Female; Human; Leukemic Infiltration; Middle Age; Mitoxantrone|AD; Prednisolone|AD; Remission Induction; Salvage Therapy; Tumor Markers, Biological; Vindesine|AD

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
0390-6078
Country of Publication
ITALY

Record 40 from database: MEDLINE
Return To Top
Return To Menu Position #30
Return To Menu Position #40

Title
Endourological management of upper tract urothelial tumors.
Author
Gerber GS; Lyon ES
Address
Department of Surgery, University of Chicago, Illinois.
Source
J Urol, 1993 Jul, 150:1, 2-7
Abstract
Advances in ureteroscopic and percutaneous techniques have made it possible to treat many upper tract malignancies by conservative, parenchyma sparing surgery. Percutaneous techniques generally allow for easier and better access to the renal pelvis and improved tumor resection. However, concerns for tumor spillage and nephrostomy tract seeding make the ureteroscopic approach best for initial management of accessible renal pelvic lesions, particularly when the diagnosis is unclear. Ureteral tumors, especially those arising in the lower third of the ureter, are technically easier to treat endoscopically than are renal pelvic tumors. Fulguration or laser photocoagulation may be used to ablate the tumor following cold-cup biopsy for histological diagnosis. Supplemental therapy using laser treatment of the tumor base, and postoperative instillation of BCG and mitomycin C offer great potential benefit in terms of improved tumor control. Confirmation of such benefit awaits the results of larger trials. Presently, standard nephroureterectomy remains the procedure of choice for most transitional cell carcinomas of the upper urinary tract in patients with a normal contralateral kidney. For those with a solitary kidney, renal insufficiency, bilateral tumors or severe intercurrent disease preventing a major open operation conservative management using endoscopic techniques is a viable alternative. Overall, it appears that grade and stage are far more important determinants of long-term out-come than the type of operation in those with transitional cell carcinoma of the upper urinary tract. For this reason, some physicians have recommended conservative management of low grade, noninvasive lesions even in the face of a normal opposite kidney. However, the majority of patients with upper tract urothelial tumors are best treated by nephroureterectomy, which leads to a low risk of local recurrence and obviates the need for rigorous postoperative upper tract surveillance.
Language of Publication
English
Unique Identifier
93287305

Return To Top
Return To Menu Position #30
Return To Menu Position #40


MeSH Heading (Major)
Carcinoma, Transitional Cell|*SU; Endoscopy|*; Kidney Neoplasms|*SU; Punctures|*; Ureteral Neoplasms|*SU
MeSH Heading
Human; Kidney Pelvis

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, ACADEMIC
ISSN
0022-5347
Country of Publication
UNITED STATES

Record 41 from database: MEDLINE
Return To Top
Return To Menu Position #30
Return To Menu Position #40

Title
Hyperreactio luteinalis associated with pregnancy: a case report and review of the literature.
Author
Schnorr JA Jr; Miller H; Davis JR; Hatch K; Seeds J
Address
Department of Obstetrics and Gynecology, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
Source
Am J Perinatol, 1996 Feb, 13:2, 95-7
Abstract
Hyperreactio luteinalis is a condition associated with bilateral and, in rare cases, unilateral ovarian enlargement due to theca lutein cysts. Hyperreactio luteinalis is a benign condition, usually found incidentally at cesarean section, which can appear anaplastic and lead to unnecessary ovarian resection. A 21-year-old Hispanic woman, G2P1, presented at 19 weeks with a singleton pregnancy, bilaterally enlarged ovaries, and a normal beta hCG. Over the next four months, her ovaries increased 75% in size with the right ovary becoming entrapped in the pelvis. The patient underwent a primary low transverse cesarean section. The ovaries had an anaplastic appearance and on frozen section revealed multiple benign theca lutein cysts. There are 51 reported cases of hyperreactio luteinalis associated with a normal pregnancy in the literature. It is estimated that approximately 60% of the cases of hyperreactio luteinalis unassociated with trophoblastic disease occur with normal singleton pregnancy. There are multiple benign ovarian lesions including hyperreactio luteinalis that can mimic ovarian neoplasms. Accordingly, it is important to exclude these from the differential diagnosis via a wedge biopsy and frozen section to avoid unnecessary surgical excision.
Language of Publication
English
Unique Identifier
96230891

Return To Top
Return To Menu Position #30
Return To Menu Position #40


MeSH Heading (Major)
Ovarian Cysts|*/DI/EP; Pregnancy Complications|*/DI/EP
MeSH Heading
Adult; Case Report; Diagnosis, Differential; Female; Human; Pregnancy

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
0735-1631
Country of Publication
UNITED STATES

Record 42 from database: MEDLINE
Return To Top
Return To Menu Position #30
Return To Menu Position #40

Title
Primary central nervous system lymphomas--an update [editorial]
Author
Jellinger KA; Paulus W
Address
 
Source
J Cancer Res Clin Oncol, 1992, 119:1, 7-27
Abstract
Primary CNS lymphomas (PCNSL), until recently representing about 1% of all brain tumors, show dramatically increased incidence both in high-risk groups (immunocompromised, AIDS) and in the general population. They are extranodal diffuse non-Hodgkin's lymphomas, the morphology and classification of which are identical to those of systemic lymphomas, although PCNSL show different biological behavior and diagnosis according to the New Working Formulation and updated Kiel classification may be difficult. The majority are large B cell variants of high-grade malignancy; low-grade subtypes and T cell lymphomas are rare. Sixty per cent occur in the supratentorial space (hemispheres, periventricular) and 12% in the posterior fossa; 30% are multiple (50%-70% in AIDS). PCNSL show a male preponderance with a peak incidence in the 5th-7th decade (3rd-4th in AIDS). The duration of diffuse or focal clinical symptoms averages 1-2 months. Computed tomography and magnetic resonance imaging scans show single or multiple or diffuse, often typical lesions. Diagnosis is achieved by evaluation of stereotactic biopsy material or cerebrospinal fluid cytology using immunocytological markers. Current therapy in immunocompetent patients, radiation plus corticosteroids and pre- or postradiation polychemotherapy, shows response rates of 85% with a median survival of 17-44 months, a prognosis similar to that for glioblastoma. Meningeal PCNSL is treated with intrathecal methotrexate or cytosine arabinoside. Transliquoral seeding of PCNSL is frequent, distant metastases occurring in 6%-8%. Therapy of AIDS-related PCNSL makes use of radiation and corticosteroids, and rarely of chemotherapy. The pathogenesis of PCNSL is unknown, but Epstein-Barr virus may be a contributory factor.
Language of Publication
English
Unique Identifier
93016240

Return To Top
Return To Menu Position #30
Return To Menu Position #40


MeSH Heading (Major)
Brain Neoplasms|*/CL/DI/EP/TH; Lymphoma, Non-Hodgkin|*/CL/DI/EP/TH
MeSH Heading
Human; Immunophenotyping; Lymphoma, AIDS-Related|TH; Lymphoma, B-Cell|CL; Lymphoma, T-Cell|CL; Male; Prognosis

Publication Type
EDITORIAL; REVIEW; REVIEW, ACADEMIC
ISSN
0171-5216
Country of Publication
GERMANY

Record 43 from database: MEDLINE
Return To Top
Return To Menu Position #30
Return To Menu Position #40

Title
Pleural mesothelioma.
Author
Astoul P
Address
Department of Pulmonology, HÈopital de La Conception, Marseille, France. pastoul@ap-hm.fr
Source
Curr Opin Pulm Med, 1999 Jul, 5:4, 259-68
Abstract
The increasing incidence of malignant pleural mesothelioma (MPM), better knowledge of its pathogenesis with a strong implication of asbestos fibers, and some promising therapeutic results have led to a new interest in the management of patients with this disease. The diagnosis of MPM is easier because of new immunohistochemical markers that recognize the mesothelial cells with good specificity and sensitivity on pleural biopsy samples ideally obtained by thoracoscopy. Moreover, this endoscopic procedure allows the physician to make the diagnosis of MPM at an early stage, which is the key of the therapeutic management of this disease. If radiotherapy is necessary in preventing the malignant seeding after pleural procedures in patients, the lack of comparative studies did not show the superiority of a given treatment against another. A new international staging of the disease, however, allows physicians to discriminate several groups of patients for such comparative studies--in particular, for testing the efficacy of intrapleural therapy, e.g., cytokines--for early-stage MPM and multimodal management, i.e., extrapleural pneumonectomy, radiotherapy, and chemotherapy for more advanced diseases, has led to prolonged survival in carefully selected patients. To reach this target, all patients must be enrolled in protocols. The usual pessimism for the management of patients with malignant pleural mesothelioma is over.
Language of Publication
English
Unique Identifier
99336036

Return To Top
Return To Menu Position #30
Return To Menu Position #40


MeSH Heading (Major)
Mesothelioma|*DI/EP/*TH; Pleural Neoplasms|*DI/EP/*TH
MeSH Heading
Combined Modality Therapy; Female; France|EP; Human; Incidence; Male; Prognosis; Risk Factors; Survival Rate

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
1078-1641
Country of Publication
UNITED STATES

Record 44 from database: MEDLINE
Return To Top
Return To Menu Position #40

Title
Posterior fossa ependymomas: report of 30 cases and review of the literature.
Author
Lyons MK; Kelly PJ
Address
Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota.
Source
Neurosurgery, 1991 May, 28:5, 659-64; discussion 664-5
Abstract
Thirty patients with histologically confirmed posterior fossa ependymomas operated on between January 1976 and December 1988 were reviewed. The median age was 44 years (range, 1-69 yr). There were 7 children (aged 5 yr or younger) and 23 adults (aged 16 yr or older). There were 18 female patients and 12 male patients. Headache, nausea and vomiting, and disequilibrium were the most frequent symptoms. The most common findings were ataxia and nystagmus. Gross total resection was performed in 8 patients (27%), subtotal resection in 21 patients (70%), and biopsy in only 1 patient (3%). Tumors were low grade in 73% and high grade in 27%. Twenty-seven patients underwent posterior fossa radiotherapy (median dose, 5400 cGy). Fourteen patients also underwent spinal irradiation (median dose, 3520 cGy). Age was the only significant prognostic factor identified (P less than 0.01). The 5-year survival rates were 76% for adults and 14% for children. All 14 patients who died had recurrent or residual tumor at the primary site. This review suggests that in patients with primary posterior fossa ependymomas the following is true: 1) the young patient (5 yr old or younger) has a poor prognosis; 2) there was a trend toward a better 5-year survival rate with a gross total resection; 3) if recurrence occurs, it will be at the primary intracranial site; and 4) symptomatic spinal seeding does not occur frequently.
Language of Publication
English
Unique Identifier
91343098

Return To Top
Return To Menu Position #40


MeSH Heading (Major)
Cranial Fossa, Posterior|*; Ependymoma|DT/RT/*SU; Skull Neoplasms|DT/RT/*SU
MeSH Heading
Adolescence; Adult; Age Factors; Aged; Brain Neoplasms|DT/RT/SU; Child, Preschool; Combined Modality Therapy; Female; Human; Infant; Male; Middle Age; Prognosis; Tomography, X-Ray Computed

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW OF REPORTED CASES
ISSN
0148-396X
Country of Publication
UNITED STATES

Record 45 from database: MEDLINE
Return To Top
Return To Menu Position #40

Title
Ependymoma: results, prognostic factors and treatment recommendations.
Author
McLaughlin MP; Marcus RB Jr; Buatti JM; McCollough WM; Mickle JP; Kedar A; Maria BL; Million RR
Address
Department of Radiation Oncology, University of Florida College of Medicine, Gainesville 32610-0385, USA.
Source
Int J Radiat Oncol Biol Phys, 1998 Mar, 40:4, 845-50
Abstract
PURPOSE: To review the University of Florida experience in treating ependymomas, analyze prognostic factors, and provide treatment recommendations. METHODS AND MATERIALS: Forty-one patients with ependymoma and no metastases outside the central nervous system received postoperative radiotherapy with curative intent between 1966 and 1989. Ten patients had supratentorial lesions, 22 had infratentorial lesions, and 9 had spinal cord lesions. All patients had surgery (stereotactic biopsy, subtotal resection, or gross total resection). Most patients with high-grade lesions received radiotherapy to the craniospinal axis. Low-grade intracranial lesions received more limited treatment. Spinal cord lesions were treated using either partial spine or whole spine fields. RESULTS: Of 32 intracranial tumors, 21 recurred, all at the primary site; no spinal cord tumors recurred. Overall 10-year survival rates were 51% (absolute) and 46% (relapse-free); by tumor site: spinal cord, 100%; infratentorial, 45%; supratentorial, 20% (p = 0.002). On multivariate analysis, tumor site was the only factor that influenced absolute survival (p = 0.0004); other factors evaluated included grade, gender, age, duration of symptoms, resection extent, primary tumor dose, treatment field extent, surgery-to-radiotherapy interval, and days under radiotherapy treatment. CONCLUSIONS: Patients with supratentorial or infratentorial tumors receive irradiation, regardless of grade. Craniospinal-axis fields are used when spinal seeding is radiographically or pathologically evident. Spinal cord tumors are treated using localized fields to the primary site if not completely resected. Failure to control disease at the primary site remains the main impediment to cure.
Language of Publication
English
Unique Identifier
98189857

Return To Top
Return To Menu Position #40


MeSH Heading (Major)
Ependymoma|MO/*RT; Infratentorial Neoplasms|MO/*RT; Spinal Cord Neoplasms|MO/*RT; Supratentorial Neoplasms|MO/*RT
MeSH Heading
Adolescence; Adult; Analysis of Variance; Child; Female; Human; Male; Neoplasm Recurrence, Local; Prognosis; Radiotherapy|AE; Survival Rate

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW LITERATURE
ISSN
0360-3016
Country of Publication
UNITED STATES

Record 46 from database: MEDLINE
Return To Top
Return To Menu Position #40

Title
Current issues in techniques of prostate brachytherapy.
Author
Nori D; Moni J
Address
Department of Radiation Oncology, New York Hospital, Cornell Medical Center, Flushing 11355, USA.
Source
Semin Surg Oncol, 1997 Nov, 13:6, 444-53
Abstract
Adenocarcinoma of the prostate is the most common malignancy diagnosed among men in the United States today. Brachytherapy permits conformal radiotherapy and dose escalation, and it offers the convenience of a single-day outpatient procedure which is very attractive to patients with a busy life-style. The reported potency preservation rates with brachytherapy are superior to both external beam radiation therapy (EBRT) and surgery. The older retropubic techniques have been replaced by ultrasound or CT-guided transperineal techniques. Prostate brachytherapy may be temporary or permanent, and the planning techniques for either approach are similar. This review briefly discusses the advantages and limitations of each. Temporary techniques may be used with low dose rate or high dose rate applications. The basic steps include assessing prostate volume by any diagnostic modality (CT or ultrasonography), determining total activity needed to encompass the gland and deliver the appropriate minimum peripheral dose, and determining the pattern of placement of the seeds within the gland. Preplanning may be done either by ultrasound or by CT. The operative technique requires the visualization of the prostate in three dimensions and is performed using combination of ultrasound and fluoroscopy or fluoroscopy in two axes. The New York Hospital technique employs CT-based preplanning along with ultrasound and fluoroscopy during the operative procedure. Special circumstances that necessitate neoadjuvant hormonal therapy include interference from the pubic arch and large volume glands. An analysis of patients with stage T2a disease treated at the New York Hospital-Queens, from 1990-1995, reveals an actuarial clinical freedom from relapse of 79% at 5 years and a 5-year biochemical freedom from relapse of 64% which is comparable to that reported for similar risk groups of disease by other centers. Potency is preserved in greater than 80% of patients in our series. Patient selection criteria include the pre-treatment prostate-specific antigen (PSA) level, tumor grade (Gleason), stage of disease, and presence or absence of bilateral positive biopsies and/or perineural invasion. Based on our review of the literature and our clinical results, we have divided patients with prostate cancer into good, intermediate and poor risk groups. We recommend brachytherapy as the sole procedure for good risk patients, and a combination of external beam radiation therapy (EBRT) and brachytherapy for the intermediate risk group. Future avenues for research include a search for improved imaging techniques and possibly newer isotopes.
Language of Publication
English
Unique Identifier
98023450

Return To Top
Return To Menu Position #40


MeSH Heading (Major)
Adenocarcinoma|MO/*RT; Brachytherapy|*MT; Prostatic Neoplasms|MO/*RT
MeSH Heading
Actuarial Analysis; Aged; Combined Modality Therapy; Human; Male; Patient Selection; Radiotherapy, High-Energy; Risk Factors

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL
ISSN
8756-0437
Country of Publication
UNITED STATES

Record 47 from database: MEDLINE
Return To Top
Return To Menu Position #40

Title
Endourological management of upper tract urothelial tumors.
Author
Gerber GS; Lyon ES
Address
Department of Surgery, University of Chicago, Illinois.
Source
J Urol, 1993 Jul, 150:1, 2-7
Abstract
Advances in ureteroscopic and percutaneous techniques have made it possible to treat many upper tract malignancies by conservative, parenchyma sparing surgery. Percutaneous techniques generally allow for easier and better access to the renal pelvis and improved tumor resection. However, concerns for tumor spillage and nephrostomy tract seeding make the ureteroscopic approach best for initial management of accessible renal pelvic lesions, particularly when the diagnosis is unclear. Ureteral tumors, especially those arising in the lower third of the ureter, are technically easier to treat endoscopically than are renal pelvic tumors. Fulguration or laser photocoagulation may be used to ablate the tumor following cold-cup biopsy for histological diagnosis. Supplemental therapy using laser treatment of the tumor base, and postoperative instillation of BCG and mitomycin C offer great potential benefit in terms of improved tumor control. Confirmation of such benefit awaits the results of larger trials. Presently, standard nephroureterectomy remains the procedure of choice for most transitional cell carcinomas of the upper urinary tract in patients with a normal contralateral kidney. For those with a solitary kidney, renal insufficiency, bilateral tumors or severe intercurrent disease preventing a major open operation conservative management using endoscopic techniques is a viable alternative. Overall, it appears that grade and stage are far more important determinants of long-term out-come than the type of operation in those with transitional cell carcinoma of the upper urinary tract. For this reason, some physicians have recommended conservative management of low grade, noninvasive lesions even in the face of a normal opposite kidney. However, the majority of patients with upper tract urothelial tumors are best treated by nephroureterectomy, which leads to a low risk of local recurrence and obviates the need for rigorous postoperative upper tract surveillance.
Language of Publication
English
Unique Identifier
93287305

Return To Top
Return To Menu Position #40


MeSH Heading (Major)
Carcinoma, Transitional Cell|*SU; Endoscopy|*; Kidney Neoplasms|*SU; Punctures|*; Ureteral Neoplasms|*SU
MeSH Heading
Human; Kidney Pelvis

Publication Type
JOURNAL ARTICLE; REVIEW; REVIEW, ACADEMIC
ISSN
0022-5347
Country of Publication
UNITED STATES

Home Page -- Karl Loren Web Site Navigation Bar
Karl Loren Diet Cancer & Biopsies Oral Chelation High Cholesterol Risk Factor
Karl Loren's Personal
Diet Diary
Ultrasound Technology Karl Loren Personal Plaque Isn't Where They Say It Is
Aajonus Vonderplanitz Arthritis Karl's Adventure
 With The IRS
Bones Are Alive
Diabetes Table Of Contents Jean Ross Witch Doctors & Ethnobotany
Sugar Shopping Cart Order Karl Loren's Book
On Heart Disease
AIDS
Raw Milk Search  This Web Write To Karl Loren Right To Die
Why You Should Drink More Water Transfer Factor & The Immune System What Is A Free Radical? Methyl Sulfonyl Methane
Taheebo Tea Germanium Corruption In The American Heart Association James Coburn's Use Of MSM To Handle Arthritis
Floaters Rather Than Sinkers Toxic Metals Heart Disease Jimmy Keller -- Forbidden Medicine
The Links Below Jump To Pages On Whatever Web You Are In
Table Of Contents Search This Web Navigation Help Page
Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally.  Click here or on his name in the box below.
The Links Below Are To Various Web Sites Published By Karl Loren
Karl Loren Web Vibrant Life Web Karl Loren's Book
Super Colostrum Bulk MSM Heart Disease
Emmessar Happiness Arthritis
Instead Of Chelation Therapy Super Colostrum (2)
Karl Loren's Catalog Store Central Page For All 12 Webs!
 

I promise to answer your message -- click here to send me a personal message

Dear Karl,                                        

 

 

 

 


SUBSCRIBE:  The Vibrant Life Magazine is a free electronic weekly newsletter written and published by Vibrant life.  You can view more than 50 back issues of this publication by clicking here.  The newsletter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.  The letter has been changed to product and information news which is sent out regularly each week.

E-Mail Address:
First Name:
Last Name:

REMOVAL:  You can remove yourself from the subscription list in several different ways.  Click here to read about this entire newsletter system.  Every edition of Product and Information Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.  If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.  Thus, no one else can unsubscribe you, from some other computer, without your knowledge.  But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.

E-Mail Address:

Personal Message:  When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.  Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.  You can select particular information you would like to receive, along with the free cassette tape and catalog.